Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
12.96
+0.32 (+2.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
54
55
Next >
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
February 04, 2022
Germany's expert panel on vaccine use has recommended Novavax Inc's (NASDAQ:
Via
Benzinga
Novavax Can Still Succeed, But It’s Facing High Risks
February 03, 2022
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change for NVAX stock.
Via
InvestorPlace
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a buy yet.
Via
InvestorPlace
This Is What Whales Are Betting On Novavax
February 02, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades.
Via
Benzinga
Novavax Should Move Higher After International Distribution Efforts
February 01, 2022
In the wake of a multitude of positive press releases, NVAX stock traders should prepare for an imminent bounce in the share price.
Via
InvestorPlace
World Markets News for Tuesday
February 01, 2022
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.
Via
Talk Markets
Novavax Whale Trades Spotted
January 31, 2022
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Israel Inks COVID-19 Vaccine Deal With Novavax
January 28, 2022
Israel's Ministry of Health has agreed to purchase Novavax Inc's (NASDAQ: NVAX) protein-based COVID-19 vaccine candidate, NVX-CoV2373.
Via
Benzinga
7 Great Cheap Stocks to Buy for Solid Growth in 2022
February 01, 2022
These cheap stocks have a robust growth visibility for the coming years, making them worth considering in the current market correction.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Is Novavax Turning Around? A Technical Analysis
February 01, 2022
Novavax, Inc. shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373.
Via
Talk Markets
7 Stocks to Watch in This Current Earnings Season
February 01, 2022
In these inflationary times, analysts predict robust earnings growth especially in old economy stocks. Here are seven names to consider.
Via
InvestorPlace
Could Novavax Stock Be Due For A Reversal Soon?
January 24, 2022
Novavax Inc. (NASDAQ:NVAX) shares lost ground Monday fell ...
Via
Benzinga
64 Biggest Movers From Yesterday
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
Massive Month-End Buying of Biggest Losers
January 31, 2022
The average stock in the Russell 3,000 is now up 7% from the index’s low point last Friday as we near the final close of January 2022.
Via
Talk Markets
Is Novavax Turning Around? A Technical Analysis
January 31, 2022
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine,...
Via
Benzinga
NVAX Stock Alert: The HUGE Reason Novavax Is Shooting Higher Today
January 31, 2022
Today, investors in Novavax and NVAX stock got the news they were hoping for: the company announced an application with the FDA.
Via
InvestorPlace
The Last Day In January
January 31, 2022
The market is suspicious of the moves up to right matters.
Via
Talk Markets
Why Novavax Shares Are Rising Today
January 31, 2022
Novavax Inc (NASDAQ: NVAX) is trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its...
Via
Benzinga
Novavax: The Fall of a Covid-19 Vaccine Star
January 31, 2022
Novavax is finally starting to deliver effective Covid-19 vaccines in quantity around the world, but investors have moved on from NVAX stock.
Via
InvestorPlace
32 Stocks Moving In Monday's Mid-Day Session
January 31, 2022
Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Friday. The company, last week, priced its IPO at $6 per share. Knightscope, Inc. (...
Via
Benzinga
18 Stocks Moving in Monday's Pre-Market Session
January 31, 2022
Gainers FGI Industries Ltd. (NASDAQ: FGI) rose 92.8% to $7.27 in pre-market trading after jumping 19% on Friday. The company, last week, priced its IPO at $6 per...
Via
Benzinga
52 Biggest Movers From Friday
January 31, 2022
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...
Via
Benzinga
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
NVAX stock would benefit if it the company finally wins approval from the FDA
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Uncertain Market Conditions And Good News Make Novavax A Cautious Buy
January 25, 2022
An emergency use authorization in Australia is the latest example of the “yeah but” narrative that has plagued NVAX stock for the past year.
Via
InvestorPlace
Novavax Continues to Require Patience, But It Should Pay Off
January 25, 2022
NVAX stock dropped precipitously of late, but investors with patience and a long view won't lose that patience as revenues start to roll in.
Via
InvestorPlace
Novavax Appears to be Running Out of Options
January 25, 2022
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point.
Via
InvestorPlace
Looking At Novavax's Recent Whale Trades
January 24, 2022
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Novavax Is Fighting a Losing Battle on Two Fronts
January 24, 2022
Novavax could be losing ground in the vaccine war because it’s fighting a battle on two fronts. This isn’t helping NVAX stock move higher.
Via
InvestorPlace
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.